Gc. Gusekschneider et F. Erbguth, BOTULINUM TOXIN A-INDUCED PROTECTIVE PTOSIS IN INDOLENT CORNEAL ULCERS OR EROSIONS, Klinische Monatsblatter fur Augenheilkunde, 213(1), 1998, pp. 15-22
Background Botulinumtoxin A has been introduced as a local injection t
herapy of different conditions with focal muscular hypercontractions.
Ln the ophthalmologic field the toxin has proven its efficacy in the t
herapy of blepharospasm and hemifacial spasm. There are only few repor
ts on the use of a botulinum toxin A to induce a protective ptosis in
patients with persistent corneal ulcers.Patients and methods 21 patien
ts who failed to respond to conservative therapy of corneal erosions o
r ulcers of different origin received a botulinum toxin A injection in
to the levator palpebrae superioris muscle. Results The ptosis began a
fter a mean of 1.5 days (1-3 days) and was complete after a mean of 5.
1 days (3-12 days) after injection. Complete recovery of the levator f
unction could be observed after a mean of 12.4 weeks (4-24 weeks). In
13 patients (61,8%) the botulinum toxin A induced protective ptosis le
ad to a complete healing of indolent ulcers or erosions, in 4 patients
(19%) an additional tarsorrhaphy was necessary. In 3 patients no heal
ing could be observed during follow up, in one patient (with neuropara
lytic ulcer) the injection was given prophylactically. The period of h
ealing on average was 3,8 weeks. There was no relationship between the
healing rate and the duration of the corneal disease prior to the bot
ulinum toxin injection. The mean healing rate of younger patients was
higher (75%) than that of older patients (53.8%) and higher in erosion
s (70%) than in ulcers (30%). No side effects were observed besides in
one patient the undesirable duration of the ptosis of a half year. Co
nclusion The induction of a protective ptosis with botulinum toxin A i
njection is an efficacious treatment alternative in persistent corneal
erosions and ulcers before performing a tarsorrhaphy. This method is
preferrable especially in patients with lagophthalmos due to facial ne
rve paresis with potential recovery.